ABG Sundal Collier acted as Joint Bookrunner in the SEK 740m secondary sale of shares in Camurus

On 11 June 2024, Sandberg Development AB (“Sandberg Development”), the largest shareholder in the leading Swedish biotechnology company Camurus AB (“Camurus” or the “Company”), announced the successful completion of the sale of 1,345,000 shares in Camurus, representing approximately 2.3 percent of the total outstanding shares and votes in the Company (the “Transaction”). The share sale was completed as a club deal to a select number of Swedish and international institutional investors and was priced at SEK 550 per share corresponding to a total deal size of approximately SEK 740m.
Following completion of the Transaction, Sandberg Development holds 20,530,692 shares in Camurus, representing approximately 35.4 percent of the total outstanding shares and votes, and thereby remains the largest shareholder in Camurus. In connection with the Transaction, Sandberg Development has entered into a lock-up agreement for the remaining shares held in the Company until the publication of Camurus’ interim report for the third quarter 2024. Thus, Sandberg Development remains a committed and long-term owner of the Company.
ABGSC acted as Joint Bookrunner in the Transaction and would like to express its gratitude to Sandberg Development for the vote of confidence.